NCLEX Questions With Rationales / Pharmacology / Drug Classes & Mechanisms
NCLEX Questions With Rationales

Clozapine NCLEX Questions With Rationales

Pharmacology · Drug Classes & Mechanisms·Updated 2026-11-19

What it is

Clozapine is an atypical antipsychotic medication primarily used to treat treatment-resistant schizophrenia when other antipsychotics have not provided an adequate response. It is also indicated to reduce recurrent suicidal behavior in clients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk. Clozapine requires careful monitoring because it can cause severe neutropenia, myocarditis, seizures, gastrointestinal complications, and significant metabolic effects.

What the NCLEX focuses on

  • Severe neutropenia: Clozapine can cause a dangerous reduction in absolute neutrophil count (ANC), increasing the risk of serious and potentially fatal infection. Obtain a baseline ANC before treatment and continue monitoring according to prescribing information.
  • Standard ANC thresholds: For clients without documented benign ethnic neutropenia, a normal ANC is at least 1,500 cells/µL. Mild neutropenia is 1,000 to 1,499 cells/µL, moderate neutropenia is 500 to 999 cells/µL, and severe neutropenia is below 500 cells/µL.
  • Low ANC management: Mild neutropenia generally allows continuation with increased monitoring. Moderate neutropenia requires interruption of clozapine, hematology consultation, and frequent ANC testing. Severe neutropenia requires discontinuation and hematology consultation.
  • Infection symptoms: Fever, sore throat, chills, mouth ulcers, or other infection symptoms require immediate assessment and notification of the prescriber. A temperature of 38.5°C (101.3°F) or higher requires interruption of treatment and an urgent ANC assessment according to prescribing information.
  • Myocarditis: Clozapine can cause myocarditis and cardiomyopathy, particularly early in treatment. Report chest pain, unexplained tachycardia, fever, dyspnea, fatigue, or flu-like symptoms promptly.
  • Gastrointestinal hypomotility: Clozapine can cause severe constipation, fecal impaction, intestinal obstruction, paralytic ileus, and potentially fatal gastrointestinal complications. Monitor bowel movements and promptly report abdominal pain, distension, vomiting, or reduced bowel activity.
  • Neurologic and cardiovascular effects: Seizures are associated with clozapine, particularly at higher doses or with rapid dose increases. Orthostatic hypotension, dizziness, syncope, sedation, and falls are also important safety concerns.
  • Metabolic effects: Monitor weight, blood glucose, and lipid levels because clozapine can cause weight gain, hyperglycemia, and dyslipidemia. Hypersalivation, especially during sleep, is another common adverse effect.
  • Smoking interaction: Tobacco smoke induces CYP1A2, which increases clozapine metabolism and can lower blood concentrations. Stopping smoking can increase clozapine levels and toxicity risk, while starting smoking can reduce therapeutic effectiveness. Report changes in smoking status to the prescriber.

Priority nursing actions

  • Verify baseline ANC results, review the medication history, assess infection symptoms, and monitor the prescribed laboratory schedule.
  • Monitor for fever, sore throat, mouth ulcers, and other infection symptoms. Hold treatment and notify the prescriber immediately when severe neutropenia or a concerning infection is suspected.
  • Assess for chest pain, tachycardia, dyspnea, and flu-like symptoms, especially during early treatment, and promptly report suspected myocarditis.
  • Monitor bowel patterns, abdominal symptoms, hydration, and prescribed bowel regimens. Report suspected ileus or obstruction immediately.
  • Monitor orthostatic blood pressure, sedation, seizure activity, weight, glucose, and lipid levels. Implement fall precautions when indicated.
  • Teach the client not to stop clozapine abruptly. If treatment has been interrupted for more than 48 hours, the prescriber must arrange reinitiation at a reduced dose with gradual retitration.

Numbers to know

ValueNumberWhy it matters
Normal ANC, standard populationAt least 1,500 cells/µLMinimum baseline and normal monitoring threshold.
Mild neutropenia1,000 to 1,499 cells/µLContinue treatment with increased ANC monitoring under prescribing guidance.
Moderate neutropenia500 to 999 cells/µLInterrupt treatment and obtain hematology consultation.
Severe neutropeniaBelow 500 cells/µLDiscontinue treatment and obtain hematology consultation.
Routine ANC monitoringWeekly for 6 monthsRecommended initial monitoring frequency.
Intermediate monitoringEvery 2 weeks for months 7 to 12Recommended monitoring after the first 6 months.
Long-term monitoringMonthly after 12 monthsRecommended ongoing monitoring frequency.

Common exam traps

  • Choosing to continue clozapine with an ANC below 500 cells/µL: wrong because this represents severe neutropenia requiring discontinuation and hematology consultation.
  • Choosing to ignore fever and sore throat: wrong because these may indicate potentially life-threatening neutropenia and infection.
  • Choosing to stop clozapine abruptly without prescriber direction: wrong because abrupt discontinuation can cause withdrawal symptoms and recurrence of psychosis.
  • Choosing to ignore constipation: wrong because clozapine-related gastrointestinal hypomotility can progress to ileus and life-threatening complications.
  • Choosing to maintain the same dose after smoking cessation without reassessment: wrong because reduced CYP1A2 induction can increase clozapine concentrations and toxicity.

What to teach

  • Explain that ANC blood monitoring continues. Since February 24, 2025, the FDA no longer expects prescribers, pharmacies, and clients to take part in the Clozapine REMS program or to report ANC results before the pharmacy dispenses clozapine, but it still recommends ANC monitoring at the frequencies in the prescribing information, and the boxed warning for severe neutropenia remains.
  • Teach the client to report fever, sore throat, chills, mouth ulcers, chest pain, shortness of breath, palpitations, and severe constipation immediately.
  • Encourage adequate hydration, physical activity as tolerated, and adherence to a prescribed bowel regimen. Report changes in bowel habits promptly.
  • Teach the client to avoid sudden changes in smoking habits without notifying the prescriber and to avoid alcohol and unapproved sedating medications.
  • Explain that clozapine may cause dizziness and sedation. Advise rising slowly from sitting or lying positions and avoiding driving until medication effects are known.
  • Reinforce adherence to prescribed doses and laboratory appointments. Never double a missed dose or restart the previous full dose after an interruption exceeding 48 hours.

2 NCLEX questions with rationales on this topic

From the NCLEXPace question bank. Choose your answer first, then open the correct answer and the full rationale under each question.

Question 1 · QID FC1CAB72

A client taking clozapine for treatment-resistant schizophrenia has an absolute neutrophil count (ANC) of 430/µL. Which action should the nurse anticipate?

Select the best answer.

  1. A. The clozapine dose will be reduced and the usual ANC schedule continued
  2. B. The medication will be stopped and hematology will be consulted
  3. C. Clozapine will continue because neutropenia is an expected effect
  4. D. The clozapine dose will be increased with frequent ANC rechecks
Show the correct answer and rationale

Correct answer:

  • B. The medication will be stopped and hematology will be consulted

Rationale

Overview

  • Definition: Clozapine-induced severe neutropenia, also called agranulocytosis, increases serious infection risk.
  • ANC thresholds: Standard categories are mild, 1,000 to 1,499/µL; moderate, 500 to 999/µL; and severe, below 500/µL. The standard baseline threshold is at least 1,500/µL.
  • Monitoring program: Monitor weekly for 6 months, every 2 weeks during months 7 to 12, then monthly.

Nursing key points

  • Withhold clozapine and notify the provider urgently.
  • Anticipate hematology consultation.
  • Obtain daily ANC until at least 1,000/µL, then follow recovery monitoring.
  • Assess for infection; report temperature of 38 C or higher immediately.
  • Use hand hygiene and avoid exposure to infectious illness.

Answer analysis

Anticipated actionRationale
The clozapine dose will be reduced and the usual ANC schedule continuedNot correct. Severe neutropenia requires discontinuation and intensified monitoring.
The medication will be stopped and hematology will be consultedCorrect. An ANC of 430/µL is severe neutropenia.
Clozapine will continue because neutropenia is an expected effectNot correct. Waiting for infection delays necessary treatment.
The clozapine dose will be increased with frequent ANC rechecksNot correct. Increasing clozapine exposure is unsafe during severe neutropenia.
Question 2 · QID 2ECC41D1

A client has just been started on clozapine for treatment-resistant schizophrenia. Which laboratory value is the priority for the nurse to monitor?

Select the best answer.

  1. A. Serum uric acid level for medication-related metabolic changes
  2. B. Serum sodium, potassium, and magnesium for electrolyte disturbances
  3. C. White blood cell count and absolute neutrophil count
  4. D. Hemoglobin A1c for clozapine-associated glucose intolerance
Show the correct answer and rationale

Correct answer:

  • C. White blood cell count and absolute neutrophil count

Rationale

Overview

  • Definition: Clozapine is a second-generation antipsychotic used for treatment-resistant schizophrenia. It carries a risk of severe neutropenia and life-threatening infection.
  • Agranulocytosis and monitoring: Absolute neutrophil count (ANC) is the priority hematologic measurement. For clients without Duffy-null associated neutrophil count, baseline ANC must be at least 1,500/mm3.
  • Other adverse effects: Myocarditis, seizures, severe constipation and gastrointestinal hypomotility, hypersalivation, weight gain, and metabolic abnormalities require additional monitoring.

Nursing key points

  • Obtain baseline ANC; monitor weekly during months 1 to 6, every 2 weeks during months 7 to 12, then monthly.
  • For clients without Duffy-null associated neutrophil count, interrupt treatment and notify the prescriber for ANC 500 to 999/mm3; discontinue for ANC below 500/mm3.
  • Recognize that clients with Duffy-null associated neutrophil count follow different ANC thresholds.
  • Teach immediate reporting of fever, sore throat, mouth ulcers, and flu-like symptoms.
  • Monitor bowel function, myocarditis symptoms, seizure activity, weight, glucose, and lipids.
  • Follow current prescribing guidance; the U.S. clozapine REMS program ended in 2025, and ANC monitoring continues.

Answer analysis

Laboratory valueRationale
Serum uric acid level for medication-related metabolic changesNot correct. Uric acid does not detect clozapine-associated neutropenia.
Serum sodium, potassium, and magnesium for electrolyte disturbancesNot correct. Electrolyte monitoring addresses other clinical risks but does not detect neutrophil suppression.
White blood cell count and absolute neutrophil countCorrect. ANC is the primary measurement for detecting clozapine-associated neutropenia and preventing severe infection.
Hemoglobin A1c for clozapine-associated glucose intoleranceNot correct. Hemoglobin A1c monitors long-term glucose control but does not detect the priority hematologic complication.
Want more questions on this topic?

The NCLEXPace bank has 3,200+ NCLEX questions with full rationales, sorted by topic, with your progress tracked as you practice. Create your account to start.

Create Account →

More topics in Pharmacology

Proton Pump Inhibitors and Antacids NCLEX Questions With RationalesReviews acid-suppressing medications, administration, adverse effects, drug interactions, and nursing priorities for gastrointestinal bleeding.Calcium Channel Blockers NCLEX Questions With RationalesReviews calcium channel blocker classes, cardiovascular uses, adverse effects, nursing assessments, medication safety, and client teaching.Statins NCLEX Questions With RationalesReviews statin medications, LDL reduction, adverse effects, drug interactions, laboratory monitoring, and client education.

Sources

Practice the NCLEX questions on this topic

3,200+ NCLEX questions with think-like-a-nurse rationales, unfolding case studies and adaptive readiness exams. Start with free practice questions, then choose a plan when you are ready.

Create Account →